Neil Kumar, CEO: BridgeBio Pharma BBIO Sell · Filed 25/01/30

Trade details

Type: Insider sale
Amount: $11,864,362.28
Shares · price: 326,932 sh · $36.29 a share
Held after: 5,371,515 sh
Stock: BridgeBio Pharma BBIO
Person: Neil KumarCEO
Trade date: 25/01/28
Filed: 25/01/30
Days to filing: 2 days

Sold 5.7% of holdings

Share of holding sold: 5.7%

BridgeBio Pharma trades, last 26 weeks

What else happened in BridgeBio Pharma around then

Filed or reported within 30 days of the trade day · 24/12/29~25/02/27

Neil Kumar's recent trades

Neil KumarDirector, Officer
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$2.5M
30,000 sh
$2.5M
Filed 08/19
Traded 08/19
Neil KumarDirector, Officer
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 plan
BridgeBio Pharma
BBIO
$2.8M
34,980 sh
$2.8M
Filed 08/18
Traded 08/18
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$1.1M
15,921 sh
$1.1M
Filed 06/08
Traded 06/04
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$1.1M
15,921 sh
$1.1M
Filed 06/08
Traded 06/04
Neil KumarCEO
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 plan
BridgeBio Pharma
BBIO
$572.7K
8,437 sh
$572.7K
Filed 06/08
Traded 06/05

Neil Kumar, CEO — sold $11.9M of BridgeBio Pharma BBIO · 5.7% of holdings · 10b5-1 plan | Whalegun